555 related articles for article (PubMed ID: 25247711)
1. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
3. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
5. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
6. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
7. An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments.
Murali VS; Chang BJ; Fiolka R; Danuser G; Cobanoglu MC; Welf ES
BMC Cancer; 2019 May; 19(1):502. PubMed ID: 31138163
[TBL] [Abstract][Full Text] [Related]
8. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
[TBL] [Abstract][Full Text] [Related]
9. A Three-Dimensional
Swaminathan S; Cranston AN; Clyne AM
Tissue Eng Part C Methods; 2019 Oct; 25(10):609-618. PubMed ID: 31441384
[TBL] [Abstract][Full Text] [Related]
10. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
Breslin S; O'Driscoll L
Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
[TBL] [Abstract][Full Text] [Related]
11. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.
Luca AC; Mersch S; Deenen R; Schmidt S; Messner I; Schäfer KL; Baldus SE; Huckenbeck W; Piekorz RP; Knoefel WT; Krieg A; Stoecklein NH
PLoS One; 2013; 8(3):e59689. PubMed ID: 23555746
[TBL] [Abstract][Full Text] [Related]
13. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.
Hongisto V; Jernström S; Fey V; Mpindi JP; Kleivi Sahlberg K; Kallioniemi O; Perälä M
PLoS One; 2013; 8(10):e77232. PubMed ID: 24194875
[TBL] [Abstract][Full Text] [Related]
14. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
Zoetemelk M; Rausch M; Colin DJ; Dormond O; Nowak-Sliwinska P
Sci Rep; 2019 May; 9(1):7103. PubMed ID: 31068603
[TBL] [Abstract][Full Text] [Related]
15. High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing.
Yan X; Zhou L; Wu Z; Wang X; Chen X; Yang F; Guo Y; Wu M; Chen Y; Li W; Wang J; Du Y
Biomaterials; 2019 Apr; 198():167-179. PubMed ID: 29807624
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
Kulesza J; Pawłowska M; Augustin E
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
[TBL] [Abstract][Full Text] [Related]
18. Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles.
Kang A; Seo HI; Chung BG; Lee SH
Nanomedicine; 2015 Jul; 11(5):1153-61. PubMed ID: 25752856
[TBL] [Abstract][Full Text] [Related]
19. Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases.
Booij TH; Klop MJ; Yan K; Szántai-Kis C; Szokol B; Orfi L; van de Water B; Keri G; Price LS
J Biomol Screen; 2016 Oct; 21(9):912-22. PubMed ID: 27412535
[TBL] [Abstract][Full Text] [Related]
20. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
